Cooper Companies (NASDAQ:COO) Updates Q1 2026 Earnings Guidance

04 Dec 2025, 18:52 by Jessica Moore · The Cerbat Gem

Cooper Companies (NASDAQ:COO – Get Free Report) issued an update on its first quarter 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 1.020-1.040 for the period, compared to the consensus EPS estimate of 1.000. The company issued revenue guidance of $1.0 billion-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Cooper Companies also updated its FY 2026 guidance to 4.450-4.600 EPS.

Cooper Companies Stock Performance

Cooper Companies stock traded up $1.05 during midday trading on Thursday, reaching $77.03. 5,111,518 shares of the stock traded hands, compared to its average volume of 2,409,478. Cooper Companies has a fifty-two week low of $61.78 and a fifty-two week high of $104.47. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The firm has a market cap of $15.31 billion, a price-to-earnings ratio of 37.95, a PEG ratio of 1.90 and a beta of 1.05. The firm has a fifty day moving average price of $71.81 and a two-hundred day moving average price of $71.70.

Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, equities research analysts forecast that Cooper Companies will post 3.98 earnings per share for the current year.

Cooper Companies announced that its Board of Directors has authorized a stock repurchase plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to buy up to 15.4% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on COO. Weiss Ratings reissued a “hold (c-)” rating on shares of Cooper Companies in a research note on Monday. Morgan Stanley set a $76.00 price objective on shares of Cooper Companies and gave the stock an “equal weight” rating in a report on Thursday, August 28th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $72.00 target price on shares of Cooper Companies in a research report on Thursday, November 13th. The Goldman Sachs Group set a $64.00 target price on shares of Cooper Companies and gave the company a “sell” rating in a research note on Wednesday, October 1st. Finally, Robert W. Baird dropped their price target on shares of Cooper Companies from $97.00 to $85.00 and set an “outperform” rating on the stock in a research report on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $84.77.

Get Our Latest Analysis on Cooper Companies

Insider Activity at Cooper Companies

In other news, COO Gerard H. Warner III bought 1,450 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were purchased at an average cost of $69.23 per share, with a total value of $100,383.50. Following the completion of the acquisition, the chief operating officer directly owned 18,319 shares in the company, valued at approximately $1,268,224.37. The trade was a 8.60% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Albert G. White III purchased 10,000 shares of the company’s stock in a transaction on Friday, September 5th. The stock was acquired at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the transaction, the chief executive officer owned 226,151 shares of the company’s stock, valued at $15,466,466.89. This represents a 4.63% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 13,450 shares of company stock valued at $921,064 over the last 90 days. 1.98% of the stock is currently owned by corporate insiders.

Institutional Trading of Cooper Companies

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. IFP Advisors Inc raised its stake in Cooper Companies by 2,647.8% during the 3rd quarter. IFP Advisors Inc now owns 632 shares of the medical device company’s stock valued at $43,000 after purchasing an additional 609 shares during the period. CIBC Bancorp USA Inc. acquired a new position in Cooper Companies during the third quarter valued at $1,887,000. Danske Bank A S acquired a new position in Cooper Companies during the third quarter valued at $6,392,000. Advisory Services Network LLC purchased a new stake in Cooper Companies in the 3rd quarter worth about $163,000. Finally, Armistice Capital LLC acquired a new stake in Cooper Companies during the 3rd quarter worth about $392,000. 24.39% of the stock is owned by institutional investors and hedge funds.

About Cooper Companies

(Get Free Report)